微信内可能无法直接打开本站。请点右上角 ··· → 在浏览器打开，或复制链接。
STAT+: Five burning questions on Trump’s latest deals with drugmakers
RSS 官方收录 · 可信分层展示
关键摘要
The Trump administration on Monday announced a second group of pharmaceutical companies had pledged to lower drug prices to levels comparable to those in other nations.…
- But the details of the deals, which President Trump has touted from th…
- Some key questions remain — including whether all the companies in the…
- (The White House did not respond to requests for comment about these q…
摘要引擎：抽取
正文提要
The Trump administration on Monday announced a second group of pharmaceutical companies had pledged to lower drug prices to levels comparable to those in other nations.
But the details of the deals, which President Trump has touted from the White House as one of the most important breakthroughs in health care, aren’t public. Some key questions remain — including whether all the companies in the second wave would avoid tariffs or otherwise mandatory Medicare drug pricing pilot programs. (The White House did not respond to requests for comment about these questions.)
Here are some of the biggest questions about the agreements.